Australia Day Honours 2018

 

COMPANION (AC) IN THE GENERAL DIVISION OF THE ORDER OF AUSTRALIA

Dr Mukesh Chandra HAIKERWAL AO, Altona North Vic 3025.
For eminent service to medical governance, administration, and technology, and to medicine, through leadership roles with a range of organisations [including presidency of the Australian Medical Association in 2005-2007], to education and the not-for-profit sector, and to the community of western Melbourne.

 

OFFICER (AO) IN THE GENERAL DIVISION OF THE ORDER OF AUSTRALIA

Professor Ronald Paul MITCHELL, North Sydney NSW 2060
For distinguished service to ophthalmology as a clinician, particularly in the management of age-related macular degeneration, through research into public health and ophthalmic epidemiology, and as an educator.

 

MEMBER (AM) IN THE GENERAL DIVISION OF THE ORDER OF AUSTRALIA

Gillian Margaret GALE, Box Hill North Vic 3129
For significant service to children who are blind or have low vision as an educator, and to learning support and education integration programs.

Dr Philip Haywood HOUSE, WA
For significant service to medicine as an ophthalmologist, to eye surgery foundations, and to the international community of Timor Leste.

Dr Ross Kenneth LITTLEWOOD, Cottesloe WA 6011. For significant service to medicine as an ophthalmologist, to professional medical organisations, and to the international community of Timor Leste.

3

MEDAL (OAM) OF THE ORDER OF AUSTRALIA IN THE GENERAL DIVISION

Mr Winston Lloyd JONES, Nedlands WA 6009.

Read More >

By | February 5th, 2018|People|

Three giants in US to form independent health-care company

Three corporate behemoths — Amazon, Berkshire Hathaway and JPMorgan Chase — announced on 30 January that they will form an independent health-care company for their employees in the United States.

The alliance is regarded as a sign of just how frustrated American businesses are with the nation’s health care system and the rapidly spiralling cost of medical treatment.

It will also cause further turmoil in an industry reeling from attempts by new players to attack a notoriously inefficient, intractable web of medical practitioners, hospitals, insurers and pharmaceutical companies.

It is not clear how extensively the three partners will overhaul their employees’ existing health coverage — whether they would simply help workers find a local doctor, steer employees to online medical advice or use their muscle to negotiate lower prices for drugs and procedures.

While the alliance will apply only to their employees, the three corporations are so closely watched that whatever successes they have could become models for other businesses.

Major employers, from Walmart to Caterpillar, have tried for years to tackle the high costs and complexity of health care, and have grown increasingly frustrated as Congress has deadlocked over the issue, leaving many of the thorniest issues to private industry. About 151 million Americans get their health insurance from an employer.

But the 30-January announcement landed

Read More >

By | February 4th, 2018|Business|

‘Bionic’ retina implant to undergo clinical feasibility study in US

A ‘bionic’ retina implant is to undergo clinical feasibility study in the United States.

The study follows the United States Food & Drug Administration’s approval of the study of Pixium Vision’s PRIMA device.

France-based Pixium Vision says the clinical feasibility study should begin in the first half of this year at the University of Pittsburgh Medical Center.

Up to five patients who have lost their sight because of atrophic dry AMD are set to be fitted with a ‘bionic’ retinal implant designed to restore some basic visual function. Pixium’s FDA approval comes just a few months after health authorities in France permitted a similar trial there, with five patients set to receive the implant at a Paris hospital.

The PRIMA system, which uses external glasses in combination with the implant, is designed to provide partial restoration of the patient’s visual function through electrical stimulation of retinal neurons, with the sub-retina implanted stimulator replacing part of the degenerated photoreceptors.

More information: http://optics.org/news/8/12/44.

By | February 4th, 2018|Surgery|

Transplanted retinal cells cause swelling to retina; not likely to affect future clinical studies

A patient who underwent transplant surgery using retinal cells derived from artificially-derived induced pluripotent stem cells has suffered a swollen retina, according to researchers from Kobe City Medical Center General Hospital and the Japan-government-backed Riken Institute.

The research team said it is the first time a patient has developed a serious adverse reaction during the clinical research to assess the feasibility of using iPSCs.

Surgeons operated on the patient, who is in his 70s, to remove pre-retinal membrane, deemed to be the cause of the retinal oedema. The team was unable to improve the symptoms despite the administration of steroid and anti-VEGF medication.

Dr Masayo Takahashi, MD, a researcher at Riken who heads the team, said: “We cannot deny the causal correlation with iPS cells.”

Dr Takahashi said the symptom falls into the category of serious cases, as it requires hospital admission for treatment, but stressed that it is “neither a matter of great urgency nor life-threatening.”

The incident most likely will not affect future clinical studies on the transplantation of iPS-derived retinal cells in patients with severe eye diseases, Dr Takahashi said.

The patient’s condition improved after the removal of pre-retinal membrane. The team believes the oedema was caused by a reverse in the flow of a liquid solution containing retinal cells derived from iPS

Read More >

By | February 4th, 2018|Surgery|

Ulysses comments …

 

Suckers this way

One of the dailies recently carried a feature of “the latest stand-out sunnies”.

And what stand-outs they were – for people who don’t realise how silly they look wearing such convoluted styles. As for the prices – upwards from $500 or so to more than $600 for pieces of distressed wire fitted (if that’s the correct word for such shoddy workmanship) with zany lenses.

There’s one born every minute, as the saying goes.

 

Highway robbery

Indebted to Stetch Kontelj, who found time from his duties as Specsavers’   global legal director, based in Guernsey, to email an item from the Geelong Advertiser, (yes, the newspaper in Victoria): “Welcome to the new norm in Victoria, where if you can get electricity, it will cost you seven fold more than in 2007!”

No wonder people are backing off retail spending, such as for a new pair of glasses, when an essential item like electricity costs so much.

 

I’m OK, Jack

The Trans-Pacific Agreement (minus the United States) has finally been signed, after years of negotiations between the nations surrounding the Pacific Ocean.

Despite a serious outbreak of brotherly and sisterly love over it all, a flaw in the agreement opens the gate for prescription pharmaceuticals to be imported accompanied by big price increases, (from the US in particular) which

Read More >

By | February 4th, 2018|Comment|

‘Bionic’ retina implant to undergo clinical feasibility study in United States

A ‘bionic’ retina implant is to undergo clinical feasibility study in the United States.

The study follows the United States Food & Drug Administration’s approval of the study of Pixium Vision’s PRIMA device.

France-based Pixium Vision says the clinical feasibility study should begin in the first half of this year at the University of Pittsburgh Medical Center.

Up to five patients who have lost their sight because of atrophic dry AMD are set to be fitted with a ‘bionic’ retinal implant designed to restore some basic visual function. Pixium’s FDA approval comes just a few months after health authorities in France permitted a similar trial there, with five patients set to receive the implant at a Paris hospital.

The PRIMA system, which uses external glasses in combination with the implant, is designed to provide partial restoration of the patient’s visual function through electrical stimulation of retinal neurons, with the sub-retina implanted stimulator replacing part of the degenerated photoreceptors.

 

By | January 24th, 2018|Surgery|